Author Affiliations: Department of Nursing, I-Shou University (Drs Sun, Yao, and Chiang); Department of General Surgery, E-DA Cancer Hospital (Dr Hung); and Departments of Obstetrics & Gynecology (Dr Fu) and Nursing (Ms Tsai), E-DA Hospital, Kaohsiung, Taiwan, Republic of China.
Cancer Nurs. 2021 Jan/Feb;44(1):53-61. doi: 10.1097/NCC.0000000000000740.
Globally, cancer is the second leading cause of death. Breast cancer and gynecological cancer can damage patients' body image and lead to psychological distress, depression, and demoralization syndrome. No studies have explored the effect of logotherapy in gynecological cancer patients' psychological distress, depression, and demoralization.
To evaluate the effects of logotherapy on distress, depression, and demoralization in breast cancer and gynecological cancer patients.
A quasi-experimental design was used in this study, involving 61 breast cancer and gynecological cancer patients: 31 in the experimental group and 30 in the control group. Participants in the experimental group received logotherapy 4 to 6 times during the 12 weeks of intervention. Outcomes were measured by the (1) Distress Thermometer, (2) Patient Health Questionnaire, and (3) Demoralization Scale Mandarin Version (DS-MV).
Distress Thermometer did not differ between groups, but significant differences in favor of the intervention group were noted in the Patient Health Questionnaire (U = 674.500, P = .002); the DS-MV subcategories of loss of meaning (U = 706.500, P = .000), dysphoria (U = 673.000, P = .002), disheartenment (U = 670.000, P = .003), helplessness (U = 621.000, P = .022), and sense of failure (U = 629.500, P = .016); and the total score of the DS-MV (U = 728.500, P = .000).
Logotherapy was effective in the reduction of breast cancer and gynecological cancer patients' depression and demoralization.
Clinical professionals could add logotherapy to the treatment for breast cancer and gynecological cancer patients to reduce their depression and demoralization.
在全球范围内，癌症是第二大致死原因。乳腺癌和妇科癌症会损害患者的身体形象，导致心理困扰、抑郁和士气低落综合征。目前尚无研究探讨Logotherapy 对妇科癌症患者心理困扰、抑郁和士气低落的影响。
评估 Logotherapy 对乳腺癌和妇科癌症患者心理困扰、抑郁和士气低落的影响。
本研究采用准实验设计，纳入 61 例乳腺癌和妇科癌症患者：实验组 31 例，对照组 30 例。实验组患者在 12 周的干预过程中接受 4 至 6 次 Logotherapy。通过（1）痛苦温度计、（2）患者健康问卷和（3）中文版士气低落量表（DS-MV）评估结果。
两组患者的痛苦温度计得分无差异，但干预组患者的患者健康问卷得分显著更高（U = 674.500，P =.002）；DS-MV 亚量表中，意义丧失（U = 706.500，P =.000）、烦躁不安（U = 673.000，P =.002）、灰心丧气（U = 670.000，P =.003）、无助感（U = 621.000，P =.022）和失败感（U = 629.500，P =.016）以及 DS-MV 总分（U = 728.500，P =.000）的差异均具有统计学意义。
Logotherapy 可有效降低乳腺癌和妇科癌症患者的抑郁和士气低落。
临床专业人员可以在乳腺癌和妇科癌症患者的治疗中加入 Logotherapy，以减轻他们的抑郁和士气低落。
